{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:59:52Z","timestamp":1793177992788,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ajog.2015.01.059","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T04:55:50Z","timestamp":1429246550000},"page":"697-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":216,"title":["Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: The fetus at risk for anemia\u2013diagnosis and management"],"prefix":"10.1016","volume":"212","author":[{"given":"Giancarlo","family":"Mari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4854-2066","authenticated-orcid":false,"given":"Joanne","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Berghella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Sciscione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro H.","family":"Schenone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.01.059_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses (Level II-1)","volume":"342","author":"Mari","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.059_bib2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(88)91896-X","article-title":"Fetal haemoglobin measurement in the assessment of red cell isoimmunisation (Level II-3)","volume":"1","author":"Nicolaides","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.01.059_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/AOG.0b013e31817d453c","article-title":"Management of rhesus alloimmunization in pregnancy (Level III)","volume":"112","author":"Moise","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1469-0705.2001.00384.x","article-title":"Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21 (Level III)","volume":"17","author":"Smrcek","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib5","first-page":"703","article-title":"Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder (Level III)?","volume":"82","author":"Hendricks","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1442-200X.2008.02703.x","article-title":"Management and outcome in prenatally diagnosed sacrococcygeal teratomas (Level III)","volume":"50","author":"Okada","year":"2008","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ajog.2015.01.059_bib7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF01954496","article-title":"Diffuse neonatal haemangiomatosis with intra-uterine haemorrhage and hydrops fetalis: a case report (Level III)","volume":"153","author":"Wu","year":"1994","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ajog.2015.01.059_bib8","first-page":"727","article-title":"Society of Obstetricians and Gynaecologists of Canada. Parvovirus B19 infection in pregnancy (Level III)","volume":"24","author":"Crane","year":"2002","journal-title":"Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2015.01.059_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2005.11.042","article-title":"Incidence of parvovirus B19 infection among an unselected population of pregnant women in The Netherlands: a prospective study (Level II-1)","volume":"128","author":"van Gessel","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2015.01.059_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1471-0528.1998.tb10048.x","article-title":"Immediate and long term outcome of human parvovirus B19 infection in pregnancy (Level II-2)","volume":"105","author":"Miller","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0002-9378(90)90681-V","article-title":"Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study (Level II-2)","volume":"163","author":"Rodis","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib12","first-page":"81","article-title":"Risks associated with human parvovirus B19 infection (Level III)","volume":"38","year":"1989","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2015.01.059_bib13","first-page":"151","article-title":"Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy (Level II-2)","volume":"41","author":"Wong","year":"2000","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ajog.2015.01.059_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cll.2010.04.009","article-title":"Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy (Level III)","volume":"30","author":"Feldman","year":"2010","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.ajog.2015.01.059_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0029-1241884","article-title":"TAPS and TOPS: two distinct forms of feto-fetal transfusion in monochorionic twins (Level III)","volume":"213","author":"Slaghekke","year":"2009","journal-title":"Z\u00a0Geburtshilfe Neonatol"},{"key":"10.1016\/j.ajog.2015.01.059_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/AOG.0b013e318187e1ff","article-title":"Placental characteristics in monochorionic twins with and without twin anemia-polycythemia sequence (Level II-2)","volume":"112","author":"Lopriore","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/uog.6334","article-title":"Fetal intraperitoneal transfusion for iatrogenic twin anemia-polycythemia sequence after laser therapy (Level III)","volume":"33","author":"Herway","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1537-2995.1990.30490273444.x","article-title":"Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects (Level III)","volume":"30","author":"Sebring","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.ajog.2015.01.059_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/01443615.2011.626088","article-title":"Idiopathic, asymptomatic fetomaternal haemorrhage causing fetal death (Level III)","volume":"32","author":"Sinha","year":"2012","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.0001-6349.2002.00002.x","article-title":"Acute massive fetomaternal hemorrhage: case reports and review of the literature (Level III)","volume":"82","author":"Thomas","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2015.01.059_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0301-2115(96)02607-3","article-title":"Fetomaternal haemorrhage discovered after trauma and treated by fetal intravascular transfusion (Level III)","volume":"71","author":"Lipitz","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"suppl 4","key":"10.1016\/j.ajog.2015.01.059_bib22","first-page":"S49","article-title":"Fetal blood sampling in prenatal diagnosis of thalassemia at late pregnancy (Level III)","volume":"97","author":"Karnpean","year":"2014","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.ajog.2015.01.059_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000354343","article-title":"Fetal red blood cell parameters in thalassemia and hemoglobinopathies (Level III)","volume":"34","author":"Karnpean","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2015.01.059_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000204729","article-title":"Prenatal diagnosis of glucose-6-phosphate-dehydrogenase deficiency (Level III)","volume":"87","author":"Beutler","year":"1992","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ajog.2015.01.059_bib25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2141.1993.tb03119.x","article-title":"An unusual variant of congenital dyserythropoietic anaemia with mild maternal and lethal fetal disease\u00a0(Level III)","volume":"84","author":"Roberts","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2015.01.059_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2003-45286","article-title":"Fetal Diamond-Blackfan anemia associated with hydrops fetalis (Level III)","volume":"20","author":"Dunbar","year":"2003","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2015.01.059_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0223(199604)16:4<349::AID-PD854>3.0.CO;2-#","article-title":"Prenatal diagnosis of Blackfan-Diamond syndrome: case report and review of the literature (Level III)","volume":"16","author":"McLennan","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2015.01.059_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajog.2014.12.018","article-title":"clinical guideling #7: non-immune hydrops fetalis (Level III)","volume":"212","author":"Norton","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pd.2652","article-title":"Molecular determination of RHD\u00a0zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D (Level II-2)","volume":"30","author":"Pirelli","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2015.01.059_bib30","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJM199812103392402","article-title":"Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma (Level II-2)","volume":"339","author":"Lo","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.059_bib31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/pd.2770","article-title":"Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women (Level II-2)","volume":"31","author":"Bombard","year":"2011","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.ajog.2015.01.059_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/pd.4018","article-title":"Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers (Level II-1)","volume":"33","author":"Moise","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2015.01.059_bib33","doi-asserted-by":"crossref","first-page":"g5243","DOI":"10.1136\/bmj.g5243","article-title":"Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study (Level II-2)","volume":"349","author":"Chitty","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2015.01.059_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pd.1970030402","article-title":"Fetal blood sampling via the umbilical cord using a needle guided by ultrasound. Report of 66 cases (Level III)","volume":"3","author":"Daffos","year":"1983","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2015.01.059_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajog.2013.07.014","article-title":"Fetal blood sampling (Level III)","volume":"209","author":"Berry","year":"2013","journal-title":"Am J\u00a0Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJMoa052855","article-title":"DIAMOND Study Group. Doppler ultrasonography versus amniocentesis to predict fetal anemia (Level II-1)","volume":"355","author":"Oepkes","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.059_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(86)90085-2","article-title":"Have Liley charts outlived their usefulness (Level II-3)?","volume":"155","author":"Nicolaides","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9378(89)90230-5","article-title":"Does midtrimester delta OD450 of amniotic fluid reflect severity of Rh disease (Level II-3)?","volume":"161","author":"Ananth","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0002-9378(86)90303-0","article-title":"Midtrimester amniotic fluid delta optical density at 450 nm in normal pregnancies (Level III)","volume":"155","author":"Ananth","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00006250-199901000-00044","article-title":"Hemolytic disease of the fetus: a comparison of the Queenan and extended Liley methods (Level III)","volume":"93","author":"Queenan","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7863\/jum.2005.24.5.697","article-title":"Middle cerebral artery peak systolic velocity: is it the standard of care for the diagnosis of fetal anemia (Level III)?","volume":"24","author":"Mari","year":"2005","journal-title":"Ultrasound Med"},{"key":"10.1016\/j.ajog.2015.01.059_bib42","first-page":"589","article-title":"Accurate prediction of fetal hemoglobin by Doppler ultrasonography (Level III)","volume":"99","author":"Mari","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/uog.1882","article-title":"Middle cerebral artery peak systolic velocity for the diagnosis of fetal anemia: the untold story (Level III)","volume":"25","author":"Mari","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib44","first-page":"746","article-title":"Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat (Level II-2)","volume":"109","author":"Zimmerman","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2015.01.059_bib45","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1471-0528.2009.02255.x","article-title":"Noninvasive methods of detecting fetal anaemia: a systematic review and meta-analysis (Meta-Analysis)","volume":"116","author":"Pretlove","year":"2009","journal-title":"BJOG"},{"issue":"suppl 2","key":"10.1016\/j.ajog.2015.01.059_bib46","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1055\/s-0031-1281756","article-title":"Fetal anemia of unknown cause\u2014a diagnostic challenge (Level III)","volume":"32","author":"Amann","year":"2011","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.ajog.2015.01.059_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2007.10.788","article-title":"The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia (Level III)","volume":"198","author":"Moise","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.0960-7692.2001.00540.x","article-title":"Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection (Level II-2)","volume":"18","author":"Delle Chiaie","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib49","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajog.2005.08.069","article-title":"Prevalence and management of late fetal complications following successful selective laser coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome (Level II-2)","volume":"194","author":"Robyr","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000092461","article-title":"Doppler sonography of the fetal middle cerebral artery in the management of massive fetomaternal hemorrhage (Level III)","volume":"21","author":"Eichbaum","year":"2006","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2015.01.059_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7863\/jum.2005.24.4.425","article-title":"Middle cerebral artery peak systolic velocity: technique and variability (Level II-3)","volume":"24","author":"Mari","year":"2005","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.ajog.2015.01.059_bib52","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/AOG.0b013e3181a4b4b5","article-title":"The effect of fetal heart rate on the peak systolic velocity of the fetal middle cerebral artery (Level II-2)","volume":"113","author":"Swartz","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib53","doi-asserted-by":"crossref","first-page":"397.e1","DOI":"10.1016\/j.ajog.2008.11.002","article-title":"Angle correction can be used to measure peak systolic velocity in the fetal middle cerebral artery (Level III)","volume":"200","author":"Ruma","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000020813","article-title":"A\u00a0simple method to estimate volume for fetal intravascular transfusions (Level III)","volume":"13","author":"Giannina","year":"1998","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2015.01.059_bib55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0002-9378(91)90227-I","article-title":"Porencephalic cyst: a complication of fetal intravascular transfusion (Level III)","volume":"165","author":"Dildy","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0002-9378(94)70271-3","article-title":"Changes in hemorheology with fetal intravascular transfusion (Level II-2)","volume":"170","author":"Welch","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00006250-199203000-00013","article-title":"The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death (Level II-2)","volume":"79","author":"Radunovic","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000111599","article-title":"Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion (Level III)","volume":"23","author":"Fox","year":"2008","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2015.01.059_bib59","first-page":"1","article-title":"The management of Rh-Isoimmunization (Level III)","volume":"52","author":"Bowman","year":"1978","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib60","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1067\/mob.2001.118161","article-title":"Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization (Level II-3)","volume":"185","author":"Detti","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajog.2006.10.895","article-title":"High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus (Level II-2)","volume":"196","author":"Schonewille","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib62","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2011.09.024","article-title":"Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus\/newborn: the LOTUS study (Level II-2)","volume":"206","author":"Lindenburg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib63","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pd.4152","article-title":"Long-term neurodevelopmental and\u00a0cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review (Level III)","volume":"33","author":"Lindenburg","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2015.01.059_bib64","doi-asserted-by":"crossref","first-page":"204.e1","DOI":"10.1016\/j.ajog.2011.12.035","article-title":"Intrauterine transfusion for parvovirus B19\u00a0infection: long-term neurodevelopmental outcome (Level II-2)","volume":"206","author":"De Jong","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.AOG.0000249611.67873.94","article-title":"Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection (Level II-2)","volume":"109","author":"Nagel","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib66","first-page":"1232","article-title":"Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops (Level II-2)","volume":"109","author":"Dembinski","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2015.01.059_bib67","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(95)92346-2","article-title":"Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection (Level II-3)","volume":"346","author":"Fairley","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.01.059_bib68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.940","article-title":"Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases (Level II-2)","volume":"24","author":"Enders","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2015.01.059_bib69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.siny.2008.02.007","article-title":"Fetal anemia due to non-Rhesus-D red-cell alloimmunization (Level III)","volume":"13","author":"Moise","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2015.01.059_bib70","first-page":"965","article-title":"Intrauterine intravascular transfusion for severe erythroblastosis fetalis: how much to transfuse (Level II-3)?","volume":"75","author":"Plecas","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib71","first-page":"931","article-title":"Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions (Level II-2)","volume":"81","author":"Doyle","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib72","first-page":"373","article-title":"Outcome for\u00a0children treated with fetal intravascular transfusions because of severe blood group antagonism (Level II-2)","volume":"131","author":"Janssens","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2015.01.059_bib73","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9378(98)70178-4","article-title":"Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease (Level II-3)","volume":"179","author":"Hudon","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib74","first-page":"165","article-title":"Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years (Level II-2)","volume":"93","author":"Grab","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib75","first-page":"400","article-title":"Outcome of infants receiving in-utero transfusions for haemolytic disease (Level II-2)","volume":"114","author":"Farrant","year":"2001","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.ajog.2015.01.059_bib76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajog.2005.12.012","article-title":"Long-term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion (Level II-2)","volume":"195","author":"Harper","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib77","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review (Level I)","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.059_bib78","doi-asserted-by":"crossref","unstructured":"Moise KJ, Whitecar PW. Antenatal therapy for hemolytic disease. In: Hadley A, Soothill P, eds. Alloimmune disorders of pregnancy. Anemia, thrombocytopenia and neutropenia in the fetus and newborn. Cambridge (UK): Cambridge University Press; 2002.","DOI":"10.1017\/CBO9780511527043.012"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815002033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815002033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:06:47Z","timestamp":1767172007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815002033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0002937815002033"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.01.059","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: The fetus at risk for anemia\u2013diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}